|
Aug 11
|
Wall Street Analysts Predict a 37.25% Upside in Avadel (AVDL): Here's What You Should Know
|
|
Aug 10
|
Avadel Pharmaceuticals plc Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
|
|
Aug 9
|
Avadel Pharmaceuticals Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 7
|
Avadel: Q2 Earnings Snapshot
|
|
Aug 7
|
Avadel Pharmaceuticals Reports Second Quarter 2025 Financial Results and Raises 2025 Revenue Guidance
|
|
Jul 31
|
Avadel Pharmaceuticals to Provide a Corporate Update and Report Second Quarter 2025 Financial Results on August 7
|
|
Jul 10
|
Avadel Pharmaceuticals Receives Unanimous Appeals Court Affirmation for LUMRYZ FDA Approval
|
|
Jun 30
|
Avadel Pharmaceuticals Announces Unanimous Appeals Court Decision Upholding FDA Approval of LUMRYZ in Narcolepsy in Administrative Procedure Act Litigation
|
|
Jun 30
|
ASL Strategic Value Fund Issues Open Letter to Avadel Shareholders
|
|
Jun 30
|
Avadel Shareholder Seeks Ousting Drugmaker’s Entire Board
|
|
Jun 16
|
Wall Street Analysts See an 81.61% Upside in Avadel (AVDL): Can the Stock Really Move This High?
|
|
Jun 13
|
Surging Earnings Estimates Signal Upside for Avadel (AVDL) Stock
|
|
Jun 10
|
Following a 34% decline over last year, recent gains may please Avadel Pharmaceuticals plc (NASDAQ:AVDL) institutional owners
|
|
May 8
|
Avadel Pharmaceuticals First Quarter 2025 Earnings: Beats Expectations
|
|
May 8
|
Avadel Pharmaceuticals PLC (AVDL) Q1 2025 Earnings Call Highlights: Record Revenue Growth and ...
|
|
May 7
|
Appeals court reverses-in-part, vacates-in part ruling in Avadel-Jazz fight
|
|
May 7
|
Avadel: Q1 Earnings Snapshot
|
|
May 7
|
Avadel Pharmaceuticals Reports First Quarter 2025 Financial Results and Raises Guidance
|
|
May 6
|
Avadel Pharmaceuticals Announces Favorable Ruling in Appeal of Delaware Court Injunction
|
|
Feb 24
|
Avadel Pharmaceuticals Appoints Kevin Springman as Vice President of Sales
|